Anion-Transport Mechanism of a Triazole-Bearing Derivative of Prodigiosine: A Candidate for Cystic Fibrosis Therapy
Cystic fibrosis (CF) is a genetic lethal disease, originated from the defective function of the CFTR protein, a chloride and bicarbonate permeable transmembrane channel. CF mutations affect CFTR protein through a variety of molecular mechanisms which result in different functional defects. Current t...
Main Authors: | Claudia Cossu, Michele Fiore, Debora Baroni, Valeria Capurro, Emanuela Caci, Maria Garcia-Valverde, Roberto Quesada, Oscar Moran |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00852/full |
Similar Items
-
Efficient recombinant production of prodigiosin in Pseudomonas putida
by: Andreas eDomröse, et al.
Published: (2015-09-01) -
Biotechnological Activities and Applications of Bacterial Pigments Violacein and Prodigiosin
by: Seong Yeol Choi, et al.
Published: (2021-03-01) -
Optimization of Bioreactor Cultivation Parameters by Taguchi Orthogonal Array Design for Enhanced Prodigiosin Production
by: Amera Elmenshawe, et al.
Published: (2020-06-01) -
Prodigiosin Sensitizes Sensitive and Resistant Urothelial Carcinoma Cells to Cisplatin Treatment
by: Lena Berning, et al.
Published: (2021-02-01) -
In vitro ACTIVITY OF PRODIGIOSIN ISOLATED FROM Serratia marcescens IN COMBINATION WITH TWO GROUPS OF ANTIBIOTICS AGAINST GRAM-POSITIVE MICROORGANISMS
by: D. A. Ivanchenko
Published: (2020-02-01)